Need professional-grade analysis? Visit stockanalysis.com
$528.76M
N/A
N/A
N/A
Larimar Therapeutics Inc (LRMR) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $4.57, down 4.79% from the previous close.
Over the past year, LRMR has traded between a low of $1.79 and a high of $5.95. The stock has gained 102.2% over this period. It is currently 23.2% below its 52-week high.
Larimar Therapeutics Inc has a market capitalization of $528.76M.
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal disease. The company is based in Bala Cynwyd, Pennsylvania.
Side-by-side comparison against top Healthcare peers.